ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Sulforaphane mitigates behavioral deficits in experimental chronic kidney disease through regulation of Nrf2/NLRP3 inflammasome.
Hend S Zakaria et al.PubMed ↗Publisher ↗
No numbers read from the abstract.